380 related articles for article (PubMed ID: 8105784)
21. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
22. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
[TBL] [Abstract][Full Text] [Related]
23. [Gastric acid secretion and histamine H2 receptor antagonists].
Gespach C; Emami S; Di Gioia Y; Chastre E
Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
[No Abstract] [Full Text] [Related]
24. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
25. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
26. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
Okabe S; Nishida T; Igata H; Takagi K
Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
[TBL] [Abstract][Full Text] [Related]
27. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
[TBL] [Abstract][Full Text] [Related]
28. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
29. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
Nakano M; Kitano S; Nanri M; Kiniwa M
Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
[TBL] [Abstract][Full Text] [Related]
30. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
Cavanagh RL; Buyniski JP; Schwartz SE
J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
[TBL] [Abstract][Full Text] [Related]
31. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
33. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
34. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
36. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist.
McIsaac RL; Johnston BJ; Flannery MC
J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998
[TBL] [Abstract][Full Text] [Related]
37. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
38. The effect of different histamine H2-receptor antagonists on the gastric acid secretion of the isolated whole stomach of the mouse and on the heart rate of spontaneously beating atrium of the guinea-pig.
Szelenyi I; Postius S
Arzneimittelforschung; 1984; 34(7):787-8. PubMed ID: 6149753
[TBL] [Abstract][Full Text] [Related]
39. Chemical and biologic characteristics of roxatidine acetate.
Bickel M; Herling AW; Schoelkens B; Scholtholt J
Scand J Gastroenterol Suppl; 1988; 146():78-88. PubMed ID: 2906471
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]